Notably, although inhibition of IGF-1/IGF-1R signalling has different effects in a phase-dependent manner during the course of acute lung injury, IGF-1 stimulation consistently improves the conditions from the acute phase to the recovery phase. The gene discussed is IGF1R; the disease is injury.